GILEAD SCIENCES, INC. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Ikena Oncology, Inc. (IKNA)

Filing Manager: GILEAD SCIENCES, INC.
Reporting Manager: GILEAD SCIENCES INC
Security: Ikena Oncology, Inc. Common Stock
Symbol: IKNA
Shares outstanding: 42.3M shares
Disclosed Ownership: 1.52M shares
Ownership: 3.6%
Form type: SCHEDULE 13G/A
Date filed: 2/13/2025, 04:22 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GILEAD SCIENCES INC	3.6%	1.52M	1.52M	0	/s/ Andrew Dickinson	Andrew Dickinson, Chief Financial Officer